WallStSmart
AMPH

Amphastar P

NASDAQ: AMPH · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC

$23.90
+2.18% today

Updated 2026-05-06

Market cap
$974.42M
P/E ratio
10.78
P/S ratio
1.35x
EPS (TTM)
$2.03
Dividend yield
52W range
$17 – $31
Volume
0.6M

Amphastar P (AMPH) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
5 of 8
Last 8 quarters
Avg EPS surprise
+3.4%
Last 4 quarters
Revenue YoY growth
-1.8%
Most recent quarter
EPS YoY growth
-20.7%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
+4.1%
Last 3 reports
Positive reaction rate
67%
2 of 3 quarters
Largest single-day move
+14.4%
2025-08-07
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-04$0.73-21.1%$19.83$20.44+3.1%
2025-11-06$0.93+12.4%$25.31$24.03-5.1%
2025-08-07$0.85+14.9%$20.82$23.81+14.4%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$0.93$0.73-21.1%$183.10M-1.8%
2025-09-30$0.83$0.93+12.4%$191.84M+1.6%
2025-06-30$0.74$0.85+14.9%$174.41M-4.4%
2025-03-31$0.69$0.74+7.6%$170.53M-0.8%
2024-12-31$0.94$0.92-2.0%$186.52M+4.7%
2024-09-30$1.00$0.96-4.0%$188.82M+4.6%
2024-06-30$0.77$0.94+22.1%$182.39M+25.2%
2024-03-31$0.96$1.04+8.3%$171.84M
2023-12-31$0.93$0.88-5.4%$178.10M
2023-09-30$0.69$1.15+66.7%$180.56M
2023-06-30$0.56$0.65+16.1%$145.71M

Frequently asked questions

Has Amphastar P beaten earnings estimates?
Amphastar P has beaten Wall Street EPS estimates in 5 of its last 8 quarterly reports, with an average EPS surprise of +3.4% over the last 4 quarters.
How does AMPH stock react to earnings?
AMPH stock has moved an average of +4.1% in the trading day following earnings over its last 3 reports, with positive reactions in 67% of those quarters.
What is Amphastar P's revenue growth rate?
Amphastar P reported year-over-year revenue growth of -1.8% in its most recent quarter, with EPS growing -20.7% year-over-year.